OrthoPediatrics Corp.’s Quiet Period To Expire on November 21st (NASDAQ:KIDS)

OrthoPediatrics Corp.’s (NASDAQ:KIDS) quiet period will expire on Tuesday, November 21st. OrthoPediatrics Corp. had issued 4,000,000 shares in its IPO on October 12th. The total size of the offering was $52,000,000 based on an initial share price of $13.00. During OrthoPediatrics Corp.’s quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

KIDS has been the topic of a number of recent analyst reports. Piper Jaffray Companies initiated coverage on shares of OrthoPediatrics Corp. in a research report on Monday, November 6th. They issued an “overweight” rating and a $24.00 price objective on the stock. BTIG Research initiated coverage on shares of OrthoPediatrics Corp. in a research report on Monday, November 6th. They issued a “buy” rating and a $24.00 price objective on the stock. Stifel Nicolaus initiated coverage on shares of OrthoPediatrics Corp. in a research report on Monday, November 6th. They issued a “buy” rating and a $23.00 price objective on the stock. Finally, William Blair initiated coverage on shares of OrthoPediatrics Corp. in a research report on Monday, November 6th. They issued an “outperform” rating on the stock.

WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.com-unik.info/2017/11/18/orthopediatrics-corp-s-quiet-period-to-expire-on-november-21st-nasdaqkids.html.

OrthoPediatrics Corp. (NASDAQ KIDS) opened at $19.48 on Friday. OrthoPediatrics Corp. has a 52-week low of $17.03 and a 52-week high of $23.00.

In related news, Director Harold Ruf bought 11,500 shares of the company’s stock in a transaction that occurred on Monday, October 16th. The shares were purchased at an average cost of $13.00 per share, with a total value of $149,500.00. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.

OrthoPediatrics Corp. Company Profile

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

What are top analysts saying about OrthoPediatrics Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for OrthoPediatrics Corp. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit